MiR-373 drives the epithelial-to-mesenchymal transition and metastasis via the miR-373-TXNIP-HIF1a-TWIST signaling axis in breast cancer

Oncotarget

Volumn 6, Issue 32, 2015, Pages 32701-32712

  Chen, De ^a   Dang, Bian Li ^b   Huang, Jin zhou ^b   Chen, Min ^b   Wu, Di ^c   Xu, Man Li ^b   Li, Rong ^c   Yan, Guang Rong ^a,b  

^a Third Affiliated Hospital of Guangzhou Medical University   (China)

^b JINAN UNIVERSITY   (China)

^c SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

EMT; miR 373; ROS; TWIST; TXNIP

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; MICRORNA; MICRORNA 371; MICRORNA 373; REACTIVE OXYGEN METABOLITE; THIOREDOXIN INTERACTING PROTEIN; TRANSCRIPTION FACTOR TWIST; UNCLASSIFIED DRUG; CARRIER PROTEIN; HIF1A PROTEIN, HUMAN; MIRN373 MICRORNA, HUMAN; NUCLEAR PROTEIN; TWIST RELATED PROTEIN 1; TWIST1 PROTEIN, HUMAN; TXNIP PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST METASTASIS; CANCER PROGNOSIS; CARCINOGENESIS; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE CLUSTER; GENE FUNCTION; HUMAN; HUMAN CELL; METASTASIS; MOUSE; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; BINDING SITE; BREAST NEOPLASMS; CELL MOTION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; LUNG TUMOR; LYMPH NODE METASTASIS; MCF-7 CELL LINE; METABOLISM; NONOBESE DIABETIC MOUSE; PATHOLOGY; PROGNOSIS; PROMOTER REGION; RNA INTERFERENCE; SCID MOUSE; SECONDARY;

ANIMALS; BINDING SITES; BREAST NEOPLASMS; CARRIER PROTEINS; CELL MOVEMENT; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MCF-7 CELLS; MICE, INBRED NOD; MICE, SCID; MICRORNAS; NEOPLASM METASTASIS; NUCLEAR PROTEINS; PROGNOSIS; PROMOTER REGIONS, GENETIC; REACTIVE OXYGEN SPECIES; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TRANSFECTION; TWIST-RELATED PROTEIN 1;

EID: 84946076051     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.4702     Document Type: Article

References (34)

1. Christofori G. New signals from the invasive front. Nature. 2006; 441:444-450.
2. Yang WH, Lan HY, Huang CH, Tai SK, Tzeng CH, Kao SY, Wu KJ, Hung MC and Yang MH. RAC1 activation mediates Twist1-induced cancer cell migration. Nat Cell Biol. 2012; 14:366-374.
3. Bronsert P, Enderle-Ammour K, Bader M, Timme S, Kuehs M, Csanadi A, Kayser G, Kohler I, Bausch D, Hoeppner J, Hopt UT, Keck T, Stickeler E, Passlick B, Schilling O, Reiss CP, et al. Cancer cell invasion and EMT marker expression: a three-dimensional study of the human cancerhost interface. J Pathol. 2014; 234:410-422.
4. Gu S, Jin L, Zhang F, Sarnow P and Kay MA. Biological basis for restriction of microRNA targets to the 3' untranslated region in mammalian mRNAs. Nat Struct Mol Biol. 2009; 16:144-150.
5. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009; 136:215-233.
6. Zhang JP, Zeng C, Xu L, Gong J, Fang JH and Zhuang SM. MicroRNA-148a suppresses the epithelial-mesenchymal transition and metastasis of hepatoma cells by targeting Met/Snail signaling. Oncogene. 2014; 33:4069-4076.
7. Tsukerman P, Yamin R, Seidel E, Khawaled S, Schmiedel D, Bar-Mag T and Mandelboim O. MiR-520d-5p directly targets TWIST1 and downregulates the metastamiR miR-10b. Oncotarget. 2014; 5:12141-12150.
8. Zhang P, Huang C, Fu C, Tian Y, Hu Y, Wang B, Strasner A, Song Y and Song E. Cordycepin (3'-deoxyadenosine) suppressed HMGA2, Twist1 and ZEB1-dependent melanoma invasion and metastasis by targeting miR-33b. Oncotarget. 2015; 6:9834-9853.
9. Voorhoeve PM, le Sage C, Schrier M, Gillis AJ, Stoop H, Nagel R, Liu YP, van Duijse J, Drost J, Griekspoor A, Zlotorynski E, Yabuta N, De Vita G, Nojima H, Looijenga LH and Agami R. A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell. 2006; 124:1169-1181.
10. Huang Q, Gumireddy K, Schrier M, le Sage C, Nagel R, Nair S, Egan DA, Li A, Huang G, Klein-Szanto AJ, Gimotty PA, Katsaros D, Coukos G, Zhang L, Pure E and Agami R. The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat Cell Biol. 2008; 10:202-210.
11. Yan GR, Xu SH, Tan ZL, Liu L and He QY. Global identification of miR-373-regulated genes in breast cancer by quantitative proteomics. Proteomics. 2011; 11:912-920.
12. Patwari P, Higgins LJ, Chutkow WA, Yoshioka J and Lee RT. The interaction of thioredoxin with Txnip. Evidence for formation of a mixed disulfide by disulfide exchange. J Biol Chem. 2006; 281:21884-21891.
13. Kim SY, Suh HW, Chung JW, Yoon SR and Choi I. Diverse functions of VDUP1 in cell proliferation, differentiation, and diseases. Cell Mol Immunol. 2007; 4:345-351.
14. Zhou J and Chng WJ. Roles of thioredoxin binding protein (TXNIP) in oxidative stress, apoptosis and cancer. Mitochondrion. 2013; 13:163-169.
15. Yang MH, Wu MZ, Chiou SH, Chen PM, Chang SY, Liu CJ, Teng SC and Wu KJ. Direct regulation of TWIST by HIF-1alpha promotes metastasis. Nat Cell Biol. 2008; 10:295-305.
16. Gao P, Zhang H, Dinavahi R, Li F, Xiang Y, Raman V, Bhujwalla ZM, Felsher DW, Cheng L, Pevsner J, Lee LA, Semenza GL and Dang CV. HIF-dependent antitumorigenic effect of antioxidants in vivo. Cancer Cell. 2007; 12:230-238.
17. Lu H, Dalgard CL, Mohyeldin A, McFate T, Tait AS and Verma A. Reversible inactivation of HIF-1 prolyl hydroxylases allows cell metabolism to control basal HIF-1. J Biol Chem. 2005; 280:41928-41939.
18. Schug J. Using TESS to predict transcription factor binding sites in DNA sequence. Curr Protoc Bioinformatics. 2008; Chapter 2:Unit 2 6.
19. Liu P and Wilson MJ. miR-520c and miR-373 upregulate MMP9 expression by targeting mTOR and SIRT1, and activate the Ras/Raf/MEK/Erk signaling pathway and NFkappaB factor in human fibrosarcoma cells. J Cell Physiol. 2012; 227:867-876.
20. Loayza-Puch F, Yoshida Y, Matsuzaki T, Takahashi C, Kitayama H and Noda M. Hypoxia and RAS-signaling pathways converge on, and cooperatively downregulate, the RECK tumor-suppressor protein through microRNAs. Oncogene. 2010; 29:2638-2648.
21. Erkeland SJ, Palande KK, Valkhof M, Gits J, Danen-van Oorschot A and Touw IP. The gene encoding thioredoxininteracting protein (TXNIP) is a frequent virus integration site in virus-induced mouse leukemia and is overexpressed in a subset of AML patients. Leuk Res. 2009; 33:1367-1371.
22. Goldberg SF, Miele ME, Hatta N, Takata M, PaquetteStraub C, Freedman LP and Welch DR. Melanoma metastasis suppression by chromosome 6: evidence for a pathway regulated by CRSP3 and TXNIP. Cancer Res. 2003; 63:432-440.
23. Welsh SJ, Bellamy WT, Briehl MM and Powis G. The redox protein thioredoxin-1 (Trx-1) increases hypoxiainducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis. Cancer Res. 2002; 62:5089-5095.
24. Blagosklonny MV. Aging: ROS or TOR. Cell Cycle. 2008; 7:3344-3354.
25. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, Campbell LL, Polyak K, Brisken C, Yang J and Weinberg RA. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008; 133:704-715.
26. Klarmann GJ, Hurt EM, Mathews LA, Zhang X, Duhagon MA, Mistree T, Thomas SB and Farrar WL. Invasive prostate cancer cells are tumor initiating cells that have a stem cell-like genomic signature. Clin Exp Metastasis. 2009; 26:433-446.
27. Dong C, Yuan T, Wu Y, Wang Y, Fan TW, Miriyala S, Lin Y, Yao J, Shi J, Kang T, Lorkiewicz P, St Clair D, Hung MC, Evers BM and Zhou BP. Loss of FBP1 by SnailMediated Repression Provides Metabolic Advantages in Basal-like Breast Cancer. Cancer Cell. 2013; 23:316-331.
28. Evans AJ, Russell RC, Roche O, Burry TN, Fish JE, Chow VW, Kim WY, Saravanan A, Maynard MA, Gervais ML, Sufan RI, Roberts AM, Wilson LA, Betten M, Vandewalle C, Berx G, et al. VHL promotes E2 box-dependent E-cadherin transcription by HIF-mediated regulation of SIP1 and snail. Mol Cell Biol. 2007; 27:157-169.
29. Peinado H, Olmeda D and Cano A. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer. 2007; 7:415-428.
30. Zhou AD, Diao LT, Xu H, Xiao ZD, Li JH, Zhou H and Qu LH. beta-Catenin/LEF1 transactivates the microRNA-371-373 cluster that modulates the Wnt/betacatenin-signaling pathway. Oncogene. 2012; 31:2968-2978.
31. Yan GR, Zou FY, Dang BL, Zhang Y, Yu G, Liu X and He QY. Genistein-induced mitotic arrest of gastric cancer cells by downregulating KIF20A, a proteomics study. Proteomics. 2012; 12:2391-2399.
32. Zhu YY, Yu G, Zhang Y, Xu Z, Wang YQ, Yan GR and He QY. A novel andrographolide derivative AL-1 exerts its cytotoxicity on K562 cells through a ROS-dependent mechanism. Proteomics. 2013; 13:169-178.
33. Xu SH, Huang JZ, Xu ML, Yu G, Yin XF, Chen D and Yan GR. ACK1 promotes gastric cancer epithelial-mesenchymal transition and metastasis through AKT-POU2F1-ECD signalling. J Pathol. 2015; 236:175-185.
34. Schindl M, Schoppmann SF, Samonigg H, Hausmaninger H, Kwasny W, Gnant M, Jakesz R, Kubista E, Birner P and Oberhuber G. Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer. Clin Cancer Res. 2002; 8:1831-1837.